30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now

Healthcare Sector Insider Trading Activity

Track insider buying and selling in Healthcare stocks. See which executives are buying, net insider activity, and % of float traded across 3,186 companies.
The information provided in this screen is for informational purposes only and does not constitute financial advice. We do not endorse any specific investment based on these criteria.
Companies
Data
Subscribe to access full data
Company Business Sector Market cap ($) # net buying insiders Net value bought ($) % of float bought % of shares held by insiders
Pharmaceuticals & Medical Research Nano (46.9mn) 0 No activity 15–50%
Pharmaceuticals & Medical Research Nano (46.8mn) 0 No activity 0–15%
Healthcare Services Nano (46.7mn) 0 No activity 15–50%
Pharmaceuticals & Medical Research Nano (46.5mn) 0 No activity 0–15%
Healthcare Services Nano (46.3mn) 0 No activity 50%+
Pharmaceuticals & Medical Research Nano (46.3mn) 1–5 $100K–$1M 0–15% 15–50%
FR Novacyt SA (ALNOV)
Pharmaceuticals & Medical Research Nano (45.9mn) 0 No activity 0–15%
Healthcare Services Nano (45.9mn) -1–5 -$100K–$1M -0–15% 0–15%
Pharmaceuticals & Medical Research Nano (45.6mn) 0 No activity 0–15%
Healthcare Services Nano (45.6mn) 0 No activity 15–50%
Pharmaceuticals & Medical Research Nano (45.4mn) -1–5 -< $100K -0–15% 0–15%
Pharmaceuticals & Medical Research Nano (45.2mn) -1–5 -< $100K -0–15% 15–50%
Pharmaceuticals & Medical Research Nano (45.0mn) 0 No activity 15–50%
Healthcare Services Nano (44.4mn) 1–5 < $100K 0–15% 15–50%
Pharmaceuticals & Medical Research Nano (44.4mn) 0 No activity 0–15%
Pharmaceuticals & Medical Research Nano (44.4mn) 0 No activity 50%+
Pharmaceuticals & Medical Research Nano (44.2mn) 0 No activity 0–15%
Healthcare Services Nano (44.1mn) 6–10 $100K–$1M 0–15% 0–15%
IN Lyka Labs Ltd (LYKALABS)
Pharmaceuticals & Medical Research Nano (44.1mn) 0 No activity 15–50%
Pharmaceuticals & Medical Research Nano (43.4mn) 0 No activity 0–15%
Pharmaceuticals & Medical Research Nano (43.1mn) 0 No activity 0–15%
Healthcare Services Nano (42.9mn) 0 No activity 15–50%
IN Albert David Ltd (ALBERTDAVD)
Pharmaceuticals & Medical Research Nano (42.8mn) 0 No activity 50%+
Healthcare Services Nano (42.8mn) 0 No activity 15–50%
Pharmaceuticals & Medical Research Nano (42.3mn) 0 No activity 50%+
Healthcare Services Nano (42.2mn) 0 No activity 0–15%
SE Medivir AB (MVIR-B)
Pharmaceuticals & Medical Research Nano (41.9mn) 0 No activity 15–50%
Pharmaceuticals & Medical Research Nano (41.4mn) 0 No activity 15–50%
Pharmaceuticals & Medical Research Nano (41.4mn) 0 No activity 0–15%
Pharmaceuticals & Medical Research Nano (41.3mn) 1–5 < $100K 0–15% 15–50%
Pharmaceuticals & Medical Research Nano (41.1mn) 0 No activity 0–15%
Pharmaceuticals & Medical Research Nano (40.8mn) 0 No activity 15–50%
Healthcare Services Nano (40.4mn) 0 No activity 0–15%
Pharmaceuticals & Medical Research Nano (40.3mn) 0 No activity 0–15%
Healthcare Services Nano (39.7mn) 0 No activity 15–50%
Pharmaceuticals & Medical Research Nano (39.7mn) 0 No activity 0–15%
Pharmaceuticals & Medical Research Nano (39.5mn) 0 No activity 0–15%
Pharmaceuticals & Medical Research Nano (39.5mn) 0 No activity 15–50%
Pharmaceuticals & Medical Research Nano (39.3mn) 0 No activity 15–50%
Pharmaceuticals & Medical Research Nano (39.3mn) 0 No activity 0–15%
SE Q linea AB (QLINEA)
Healthcare Services Nano (39.0mn) 1–5 < $100K 0–15% 0–15%
Healthcare Services Nano (38.9mn) 0 No activity
Pharmaceuticals & Medical Research Nano (38.4mn) 0 No activity 0–15%
Healthcare Services Nano (38.4mn) 0 No activity 15–50%
US Veru Inc (VERU)
Pharmaceuticals & Medical Research Nano (38.4mn) 0 No activity 0–15%
Pharmaceuticals & Medical Research Nano (38.0mn) 0 No activity 15–50%
Pharmaceuticals & Medical Research Nano (37.8mn) 0 No activity 15–50%
Healthcare Services Nano (37.8mn) 1–5 < $100K 0–15% 0–15%
Healthcare Services Nano (37.6mn) 0 No activity 15–50%
Pharmaceuticals & Medical Research Nano (37.5mn) 0 No activity 15–50%
Pharmaceuticals & Medical Research Nano (37.2mn) 0 No activity 50%+
Pharmaceuticals & Medical Research Nano (36.8mn) 0 No activity 0–15%
Healthcare Services Nano (36.5mn) 1–5 < $100K 0–15% 0–15%
Pharmaceuticals & Medical Research Nano (36.4mn) 0 No activity 15–50%
SE Acarix AB (ACARIX)
Healthcare Services Nano (36.0mn) 0 No activity 0–15%
Pharmaceuticals & Medical Research Nano (35.8mn) 0 No activity 0–15%
Pharmaceuticals & Medical Research Nano (35.7mn) 0 No activity 15–50%
Pharmaceuticals & Medical Research Nano (35.6mn) 0 No activity 0–15%
Pharmaceuticals & Medical Research Nano (35.5mn) 0 No activity 15–50%
Healthcare Services Nano (35.5mn) 0 No activity
Pharmaceuticals & Medical Research Nano (35.4mn) 0 No activity 0–15%
Pharmaceuticals & Medical Research Nano (34.6mn) 0 No activity 15–50%
FR Genoway SA (ALGEN)
Pharmaceuticals & Medical Research Nano (34.6mn) 0 No activity 0–15%
Healthcare Services Nano (34.5mn) 0 No activity 0–15%
Healthcare Services Nano (34.4mn) 0 No activity 15–50%
Pharmaceuticals & Medical Research Nano (34.3mn) 0 No activity 15–50%
Pharmaceuticals & Medical Research Nano (34.1mn) 0 No activity 15–50%
Pharmaceuticals & Medical Research Nano (33.3mn) 1–5 $100K–$1M 0–15% 50%+
Pharmaceuticals & Medical Research Nano (33.1mn) 1–5 < $100K 0–15% 15–50%
Pharmaceuticals & Medical Research Nano (32.9mn) 0 No activity 0–15%
Healthcare Services Nano (32.8mn) 1–5 $100K–$1M 0–15% 15–50%
Pharmaceuticals & Medical Research Nano (32.5mn) 0 No activity 0–15%
Healthcare Services Nano (32.4mn) 0 No activity 50%+
Healthcare Services Nano (32.3mn) 0 No activity 50%+
Healthcare Services Nano (32.0mn) 1–5 < $100K 0–15% 15–50%
Healthcare Services Nano (31.9mn) 0 No activity 15–50%
Healthcare Services Nano (31.8mn) 0 No activity
Pharmaceuticals & Medical Research Nano (31.7mn) 0 No activity 0–15%
Pharmaceuticals & Medical Research Nano (31.3mn) 0 No activity 0–15%
Pharmaceuticals & Medical Research Nano (31.2mn) 0 No activity 0–15%
Pharmaceuticals & Medical Research Nano (31.1mn) -1–5 -< $100K -0–15% 0–15%
SE Integrum AB (INTEG-B)
Healthcare Services Nano (30.7mn) 0 No activity 15–50%
Pharmaceuticals & Medical Research Nano (30.6mn) 0 No activity 0–15%
Pharmaceuticals & Medical Research Nano (30.4mn) 0 No activity 50%+
Pharmaceuticals & Medical Research Nano (30.4mn) 0 No activity 0–15%
Pharmaceuticals & Medical Research Nano (30.4mn) 1–5 < $100K 0–15% 0–15%
Healthcare Services Nano (30.3mn) 0 No activity 15–50%
Pharmaceuticals & Medical Research Nano (30.2mn) 0 No activity 15–50%
Pharmaceuticals & Medical Research Nano (30.2mn) 0 No activity 0–15%
Healthcare Services Nano (30.2mn) 0 No activity 50%+
Pharmaceuticals & Medical Research Nano (30.1mn) 1–5 < $100K 0–15% 0–15%
Pharmaceuticals & Medical Research Nano (30.1mn) -1–5 -$100K–$1M -0–15% 0–15%
Pharmaceuticals & Medical Research Nano (29.7mn) 0 No activity 0–15%
Healthcare Services Nano (29.4mn) 0 No activity 15–50%
Pharmaceuticals & Medical Research Nano (29.4mn) 0 No activity 50%+
Pharmaceuticals & Medical Research Nano (29.3mn) 0 No activity 0–15%
Healthcare Services Nano (29.2mn) 0 No activity 15–50%
Healthcare Services Nano (29.2mn) 0 No activity 50%+
Healthcare Services Nano (29.1mn) 0 No activity 0–15%
Healthcare Services Nano (28.9mn) 1–5 < $100K 0–15% 15–50%